Dollar Stock Club Logo

⏳ The Last Undervalued A.I. Stock in America? [adv]

Legendary Economist Shares His Top 2 Ways to Play the Gold Boom [sponsor]
One of America’s top experts, Dr. Mark Skousen, has come up a way to secure a shot at making asymmetric gains from gold’s historic bull market run. I’m not talking about a way to merely double or triple an investment… that doesn’t even scratch the surface of the opportunity I see… Because according to all the proprietary research Mark put together… Investors who choose to follow his lead could have the chance to bring home gains as high as 2,066%. Best of all, because both companies that Mark found trade for less than $20 a share, almost anyone can take advantage of this opportunity… while it lasts. I’ll show you how here.

US approves environmental review for Michigan nuclear plant restart
WASHINGTON (Reuters) -The U.S. on Friday said Holtec’s planned restart of the Palisades nuclear power plant in Michigan would not harm the environment, a needed step in its plan to become the first such plant to return from permanent shutdown.The Nuclear Regulatory Commission conducted the environmental revie …. Read More >>

Unsubscribe

Free Stock Analysis: Know the Value Before You Buy or Sell [sponsor]
Want to know if your stock is a smart move? Get a complete stock analysis that shows its true value, risk level, and buy/sell timing. This in-depth report also gives you a clear Buy, Sell, or Hold recommendation to guide your next move. Don’t guess, get facts. See a Stock’s True Value-Free Analysis with Buy/Sell Rating

Harvard’s US-funded defense projects totaled $180 million in recent years, study shows
WASHINGTON (Reuters) -When the Trump administration cut federal funding to Harvard University, it abruptly ended an estimated $180 million that the federal government had poured into U.S. military projects at Harvard in recent years, according to an analysis from a defense software company.The Trump administr …. Read More >>

Unsubscribe

7 Nuclear Stocks to Buy Before They Surge [sponsor]
Nuclear stocks are on fire – up 40% in 2024 – and the rally’s not over. 2025 could actually be bigger. Our free report, 7 Top Nuclear Stocks to Buy Now, names the top players ready to soar. From uranium miners to reactor innovators, these picks passed our strictest tests. Get your report FREE today!

Rivian eyes new debt deal as expected vehicle deliveries slump, Bloomberg News reports
The EV maker is looking to raise as much as $2 billion, partly to replace existing bonds that mature in 2026, the report said.JPMorgan is sounding out investors on the bond deal, with early pricing talks suggesting a yield around 10%.The transaction could launch as soon as next week, although the deal is stil …. Read More >>

Unsubscribe

66,000% upside on tiny biotech? [sponsor]
The Wall Street Journal reports that this medical breakthrough is “Transforming Medicine.” One analyst calculated that it could be worth $1 Trillion, making the upside potential of this small-cap 66,000% above today’s price. Get all the details here > > >

Measles cases in Texas rise by nine to 738, state health department says
The U.S. is battling one of the worst outbreaks of measles it has seen, with over 1,000 cases reported for the first time in five years and three confirmed deaths.The Centers for Disease Control and Prevention reported 1,088 confirmed cases in 33 jurisdictions as of May 29.Experts have urged public health off …. Read More >>

Disclaimer

This is a paid advertisement for educational purposes only and does not constitute financial advice. Investing involves risk and may not be suitable for all individuals. Past performance does not guarantee future results. Dollar Stock Club is owned and operated by Guardian Financial Publishing LLC. We are not licensed financial advisors. Always consult with a certified financial professional before making investment decisions.

IMPORTANT NOTICE AND DISCLAIMER
Guardian Financial Publishing LLC ), the owner of this website (the “Website”), cannot guarantee the accuracy or completeness of the information contained in any article, email, newsletter, or other publication posted on or viewed in connection with this website (the “Publications”). The author or authors of those Publications are solely responsible for their contents. IMS has not done any research or due diligence into the markets, industries, or companies which may appear or be mentioned in the Publications. IMS will NOT be liable for any loss or damage caused by a reader’s reliance on information posted on the Website or contained in the Publications.

FOR EDUCATIONAL AND INFORMATIONAL PURPOSES ONLY; NOT INVESTMENT ADVICE.
This Website and the Publications are for educational and informational purposes only. This Website and the Publications do not purport to be a complete analysis of any company’s financial position. This Website, the Publications or any statements made in the Publications are not, and should not be construed to be, personalized investment advice directed to or appropriate for any particular individual. This Website or the statements made in the Publications should NOT be relied upon for purposes of transacting in any securities posted on the Website or mentioned in the Publications, nor should they be construed as a personalized recommendation to you to buy, sell, or hold any position in any security posted on this Website or mentioned in any Publications.

SUBSTANTIAL RISK IN INVESTMENT.
Any individual who chooses to invest in any securities including those mentioned in the Publications should do so with caution. Investing or transacting in securities involves substantial risk; you may lose some, all, or possibly more than your original investment. Readers bear responsibility for their own investment research and decisions and should review all investment decisions with a licensed or registered investment professional.

NOT AN INVESTMENT ADVISOR OR REGISTERED BROKER
Neither IMS nor any of its respective owners or employees are registered or licensed as a securities broker-dealer, broker, an investment advisor, or an investment advisor representative with the U.S. Securities and Exchange Commision (SEC), any state securities regulatory authority, or any self-regulatory organization.

This message is for informational purposes only and does not constitute investment advice or an offer to buy or sell securities. Always conduct your own due diligence. The views expressed are those of the author and do not necessarily reflect those of the sender. This is a paid advertisement.

For full policies, see our: Disclaimer | Privacy Policy | Terms & Conditions

Dollar Stock Club
203 N La Salle Street, Suite 2100 | Chicago, IL 60601

Harvard’s US-funded defense projects totaled $180 million in recent years, study shows

Disclaimer

Measles cases in Texas rise by nine to 738, state health department says

Live Market Pulse

Recent Posts

Categories